Proposed H.B. No. 5485
Session Year 2025
 


AN ACT ESTABLISHING A CAPTIVE INSURANCE COMPANY TO ADMINISTER A BULK PURCHASE AND DISTRIBUTION OF GLUCAGON-LIKE PEPTIDE-1 PRESCRIPTION DRUGS TO QUALIFYING INDIVIDUALS IN THIS STATE TO TREAT OBESITY.

To establish a captive insurance company, which shall be supported by the appropriation of the sum of ten million dollars to said captive insurance company, from the General Fund, for the fiscal year ending June 30, 2026, for the purpose of (1) bulk purchasing glucagon-like peptide-1 receptor antagonist prescription drugs from drug manufacturers, and (2) distributing such prescription drugs to covered persons in this state who satisfy a means-tested qualification process and demonstrate an inability to obtain such prescription drugs from such covered person's health insurer to treat obesity.

Introduced by:
Rep. Geoff Luxenberg, 12th Dist.

 New today  2-4 days old  5 days & older
   Text of Bill
 Proposed Bill  [doc]
  View or Add Notes to HB-5485

Add Notes to HB-5485

Go To My Bills


This bill is in My Bills.
Do you wish to go to My Bills?

Co-sponsors for Amendment LCO:

Bill History

 Date Action Taken
 1/17/2025Referred to Joint Committee on Insurance and Real Estate

NOTE: Please direct all inquiries regarding the status of bills to the Office of the House Clerk and/or Senate Clerks' Office.